Literature DB >> 1100919

The incidence of pathogenic yeasts among open-heart surgery patients-the value of prophylaxis.

E G Evans.   

Abstract

The normal levels of commensal yeasts in patients undergoing open-heart surgery are established and the effect of antifungal prophylaxis is assessed. Mouth swabs and feces were taken for culture from patients on admission to hospital and 1,2, and 3 weeks postoperatively. Eighty-seven patients who received normal treatment and 50 patients who were given oral and topical antifungal prophylaxis commencing 12 days before hospitalization were studied. Yeast pathogens, mainly Candida albicans, were isolated from 42 (48.3 per cent) of the normal group on admission. There was a marked increase in the incidence and quantities of yeasts isolated from patients in the immediate postoperative period. The incidence and levels of yeasts in patients receiving antifungal prophylaxis was considerably reduced both on admission and postoperatively. The risk of Candida sepsis in open-heart surgery patients with high levels of commensal yeasts is discussed and the possibility of routine antifungal prophylaxis raised.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1100919

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Altered hepatic clearance and killing of Candida albicans in the isolated perfused mouse liver model.

Authors:  R T Sawyer; M N Horst; R E Garner; J Hudson; P R Jenkins; A L Richardson
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

2.  Persistence and spread of Candida albicans after intragastric inoculation of infant mice.

Authors:  L H Field; L M Pope; G T Cole; M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

3.  Prevalence of pathogenic yeasts and humoral antibodies to candida in diabetic patients.

Authors:  F C Odds; E G Evans; M A Taylor; J K Wales
Journal:  J Clin Pathol       Date:  1978-09       Impact factor: 3.411

4.  Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy.

Authors:  M N Guentzel; C Herrera
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.